| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | Director | Jan 16, 2024 | Sale | $2.71 | 29,399 | 79,671 | 125,153 | Jan 17, 2024, 05:21 PM | |
| NUVL | Nuvalent, Inc. | Protopapas Anna | Director | Dec 18, 2023 | Option Exercise | $9.36 | 5,000 | 46,800 | 5,000 | Dec 20, 2023, 04:58 PM | |
| NUVL | Nuvalent, Inc. | Protopapas Anna | Director | Dec 18, 2023 | Sale | $75.67 | 5,000 | 378,350 | 0 | Dec 20, 2023, 04:58 PM | |
| MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | President & CEO | Jan 17, 2023 | Sale | $5.74 | 17,346 | 99,566 | 48,733 | Jan 18, 2023, 08:24 PM | |
| MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | President & CEO | Jul 16, 2021 | Sale | $12.47 | 20,043 | 249,936 | 304,879 | Jul 19, 2021, 08:49 PM | |
| MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | President & CEO | Jul 19, 2021 | Sale | $12.02 | 21,901 | 263,250 | 282,978 | Jul 19, 2021, 08:49 PM | |
| MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | President & CEO | Jan 15, 2021 | Option Exercise | $21.09 | 5,198 | 109,626 | 224,922 | Jan 20, 2021, 07:04 PM | |
| MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | President and CEO | Dec 20, 2017 | Option Exercise | $1.53 | 10,417 | 15,938 | 130,719 | Dec 21, 2017, 04:06 PM | |
| BIVV | Bioverativ Inc. | Protopapas Anna | Director | Apr 17, 2017 | Option Exercise | $56.83 | 1,056 | 60,012 | 1,056 | Apr 17, 2017, 04:14 PM |
Menu